22 funding opportunities are listed in this category
Excellence in Care of the Older Adult With Cancer Award
Award: Monetary award of $1000 and a plaque.Purpose: To recognize and support an oncology nurse who demonstrates age sensitive health interventions, quality care, and symptom management to older adult patients with cancer.Nominee's Eligibility Criteria:The candidate must meet the following criteria: * Be a registered professional nurse (staff nurse, advanced practice nurse) and an active ONS member * Have at least two years of oncology nursing experience * Currently practice in an adult oncology based settingCriteria: The scoring criteria for judging this nomination packet is as follows: * Demonstrates evidence of significant contributions to age sensitive health interventions, quality care, and/or symptom management for the older adult with cancer * Participates in continuing education to strengthen his/her knowledge about the older adult patient and oncology nursing practice * Shares information with other professionals that was learned from continuing education offerings, and contributes to evidence based practice changes in his/her work setting * Participates in patient education activities * Serves as a role model for age sensitive health interventions, quality care, and/or symptom management for the older adult with cancer * Designs and implements innovative clinical practice improvements based on specific needs of patients, families and/or caregiversApplication deadline: August 16, 2010, 5pm (ET).
For more information on any of the ONS awards, contact ONS at customer.service@ons.org. Both nominees and nominators will be notified once an application is received.Oncology Nursing Society 125 Enterprise Drive Pittsburgh, PA15275866-257-4ONS (866-257-4667) 412-859-6100 877-369-5497 (toll free fax)412-859-6162 (fax)
Academy of Medical-Surgical Nurses Nurse Competence in Aging Award
PurposeTo honor a member of AMSN who displays excellence in providing care to older adults, serves as a role model, and mentor to other healthcare providers.AwardOne (1) $500 award and certificate.DeadlineApplications must be received in the AMSN National Office by May 15 annually, and applicants are notified by June 30 annually. Submissions received after the application deadline will not be considered.Eligibility Criteria and Award Information * Applicant must be a member of AMSN for one (1) year by application date. * The awardee will be expected to share how this award has advanced his/her professional practice. * Current members of the Board of Directors of AMSN, current members of the Medical-Surgical Nursing Certification Board, members of the Scholarship & Awards Committee, and staff are not eligible for the awards. * Each award may not be won in consecutive years and only one award may be won per year. * Applicant must have practiced for two (2) years full time as registered nurse in providing care to older adults. * May be self-nominated or nominated by a colleague. * Must show evidence of obtaining ongoing education related to older adults
Academy of Medical-Surgical Nurses (AMSN)East Holly Avenue Box 56Pitman NJ 08071866-877-2676amsn@ajj.com
College of St. Scholastica Institute on Aging and Social Work Call for Applications
Nationally recognized experts Barbara Berkman and Chandra Mehotra in research methodology lead a training institute specifically designed for social work faculty who received their doctoral degree at least three years ago in any area of social work.
Deadline for applications is April 1, 2010.
Food, lodging, and travel support will be provided to the 15 applicants selected to participate in the program.
Requirements The applicant must have a doctoral degree in any area of social work or related field. Preference will be given to applicants who hold a tenure track appointment and have conducted limited aging research. The applicant must provide a letter of support from his/her dean indicating: (a) what institutional support will be provided to make a program of aging research possible; (b) how the conduct of aging research fits with the strategic plans of the institution; and (c) how research efforts begun at the institute will be sustained. Additional letters of support are also welcome.
Completed application, curriculum vitae, and support letter(s) must be submitted by April 1, 2010.
We are especially interested in promoting diversity among program participants and encourage minority faculty members to apply.
For details and application materials, please contact the director via e-mail or write to the following address: Chandra M. Mehrotra, Ph.D., Director Research Training Institute The College of St. Scholastica 1200 Kenwood Avenue Duluth, MN 55811 Email: cmehrotr@css.edu Phone: (218) 723-6161 Fax: (218) 723-5912
Mattie J. T. Stepanek Caregiving Scholarship “If all generations of people freely and abundantly give care to others and to our world, we will have an eternal source of love and hope that fulfills the needs of all ages.”Caregivers are often viewed as expendable resources in systems of care. As a result, many caregivers are overlooked, ill-prepared and some will ultimately burn-out. The Rosalynn Carter Institute for Caregiving promotes the view that family, professional, and paraprofessional caregivers are the most valuable asset in any system of care, and they should be cultivated, preserved, developed, and valued. We believe that with proper training and support caregivers can provide quality, compassionate care at the same time that they maintain their own health, quality of life and sense of purpose. In essence, we believe that the right kind of training and education are protective factors in the lives of caregivers. The purpose of the Mattie J. T. Stepanek Caregiving Scholarship is to provide financial assistance to family, professional, or paraprofessional caregivers of any age who are seeking training or education in specific skills, procedures and strategies that lead to more effective care at the same time that they serve to protect the health and well-being of the caregiver. Four $2,500 scholarships will be awarded.Applicants should submit the following by June 1, 2010:• Scholarship application form.• If applicable, work history and experience, including most recent performance appraisal or letter of support from direct supervisor.• Education history, including (if applicable) official grade transcripts.• A resume that includes community and volunteer service experience.• A statement describing your plans to pursue a specific course of training or education that reflects the purpose of this scholarship as given above. Include links to Mattie Stepanek’s message of hope and the mission of the Rosalynn Carter Institute for Caregiving. Do not just copy a quote or statement – we are looking for your personal reflections as they relate to these.• Two or more letters of recommendation from individuals familiar with the applicant academically, professionally, or within the community
Mail application and materials by June 1, 2010 to:
Laura Bauer Granberry, Director of National InitiativesRosalynn Carter Institute for Caregiving800 GSW DriveAmericus, GA 31709
Rosalynn Carter Leadership in Caregiving Award Named in honor of a great humanitarian, the Rosalynn Carter Leadership in Caregiving Award is the highest award given in the caregiving field. This award recognizes leadership in implementing innovative partnerships between community agencies and caregiving researchers that bridge the gap between science and practice. These partnerships help move effective caregiver support programs to widespread use in the community more quickly and efficiently.The award winning team will be announced at the RCI’s National Summit to be held October 20 - 22, 2010 at Georgia Southwestern State University in Americus, Georgia. In addition to a beautiful statuette executed by renowned sculptor Frank Eliscu, designer of the Heisman Trophy, former First Lady Rosalynn Carter will present the team with a cash award of $20,000. This special cash award is to support the team’s efforts in implementing effective caregiver interventions at the community level.Winning partnerships shall have clearly demonstrated:• Dedication to developing effective evidence-based caregiver interventions that improve the health and well being of caregivers;• Collaboration and partnerships between all stakeholders in the caregiving process;• Potential for developing or more effectively using financial, educational, andhuman resources to support caregivers;• Effective reach into the target population;• Potential to serve as a model for other individuals, groups, organizations orcommunities in efforts to better support caregivers.Application Deadline July 1, 2010
Mail or Fax nomination form and supporting documents by July 1, 2010 to:
Laura Bauer Granberry, Director of National InitiativesRosalynn Carter Institute for Caregiving800 Georgia Southwestern State University DriveAmericus, GA 31709FAX: 229-931-2663
Scholarship to the National Association of Health Care Assistants' 2010 conference "NAHCAWOOD - Celebrating the Stars of Long Term Care”
Don’t miss out on your opportunity for a scholarship to NAHCA's 2010 conference "NAHCAWOOD - Celebrating the Stars of Long Term Care." The scholarship will include travel, hotel and conference registration fees. In order to win you must complete an essay with up to 500 words describing how you have proven to be a “Star of Long Term Care.” Deadline for submission is March 10, 2010. Scholarship awards will be announced on March 23, 2010.
National Association of Health Care Assistants 2709 W. 13th St. Joplin MO. 64801 Phone: 800-784-6049 | Fax: (417) 623-2230
Request for Proposals: Novel Approaches to Drug Discovery for Alzheimer’s Disease
ADDF funds drug discovery research programs from domestic and international investigators in academia and biotechnology companies. In addition, ADDF initiates, sponsors, and co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the Foundation, bringing together physicians, scientists, and policy makers worldwide.
As a biomedical venture philanthropy, ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development. We fund high risk, early stage drug discovery and development projects and catalyze scientists to enter the drug discovery field. We have adapted the operating model and principles of venture capital investing to our philanthropic mission in biomedical research. We help to create new biotechnology companies, and to fund early stage biotechnology companies, with programs dedicated to Alzheimer’s disease drug discovery. We seek a return on investment for all of our grants based on the achievement of scientific milestones. When these milestones are met, funds return to the Foundation to increase our ability to support more research.
ADDF FUNDING PROGRAMS • ADDF Academic Drug Discovery and Development Program seeks to create and support innovative translational programs for Alzheimer’s disease, related dementias and cognitive aging in academic medical centers and universities. Biomarker development studies and innovative proof of concept pilot clinical trials of new approaches to treatment, prevention and early detection are also supported.
• ADDF Biotechnology Development Program supports qualified scientific projects in existing, private, early-stage biotechnology companies. ADDF will provide support for qualified projects in more advanced companies if a clear need for non-profit funding to support the project can be demonstrated and justified.
• ADDF Biotechnology Founders Technology Transfer Program supports academic programs that are eligible for technology transfer and the start-up of new biotechnology companies. Up to 35% of funds from these awards may be employed for expenses related to company formation, such as administrative, legal, patent and third-party vendor costs. RESEARCH FUNDING PRIORITIES • Treatment of Alzheimer’s disease and cognitive aging: ADDF supports drug discovery and drug development efforts towards novel treatments for Alzheimer’s disease and related dementias, and cognitive decline associated with aging. These may include disease modifying agents for preventing or delaying progression as well as cognitive enhancers. ADDF provides funding for target validation and proof-of-concept studies, high throughput screening of chemical libraries, lead discovery and optimization, rational medicinal chemistry, and pre-clinical drug development. ADDF also supports small proof-of principle clinical research studies. • Early detection and prevention: ADDF supports the development of biomarkers, such as advanced brain imaging technologies, CSF and blood tests for the early detection of mild cognitive impairment, Alzheimer’s disease and related dementias. ADDF also supports clinical research projects to improve early detection of cognitive impairment through population-based approaches that can impact large numbers of individuals at risk. GENERAL SUBMISSION GUIDELINES Grant applications are usually solicited by private invitation. Unsolicited proposals are also accepted, but inquiries with ADDF staff are encouraged to determine the Foundation’s interest prior to application. ADDF provides support for 1 year of research with potential for future follow-on funding. We seek successful long-term partnerships with investigators and research organizations.
APPLICATION PROCEDURE Full application guidelines and further information can be found on our website (www.alzdiscovery.org). All applicants are required to complete an electronic "Letter of Intent" (LOI) available on our website. After review of the LOI, we may invite a full application via email with a link to the electronic application form. ADDF will attempt to make a determination of interest within 90 days of receipt of the application.
ADDF accepts grant applications for the “General Request for Proposals” research award programs throughout the year (2010 deadlines for full proposals are January 7, April 1, July 1, and October 1).
If you would like to contact the Foundation, please call (212) 935-2402, or contact us by regular mail at the following address:Alzheimer’s Drug Discovery Foundation1414 Avenue of the Americas, Suite 1502New York, NY 10019
RFA: Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their FamiliesAnnual Deadline: October 15thPURPOSE: The development of the specialty of palliative medicine has been a critical step in addressing the unmet needs of patients with serious illness and their families and the growth of this field has been remarkable. Nevertheless, the field faces sizeable challenges if care for seriously ill patients and their families is to improve. Unlike other areas of medicine, the knowledge base to support the basic elements of palliative care clinical practice (i.e., pain and symptom management, communication skills, care coordination) is small and inadequate and systems of care that have been developed to support the needs of patients and families have yet to be evaluated. Over the past eight years, a series of reports from the Institute of Medicine, the National Institutes of Health, and the American Academy of Hospice and Palliative Medicine have called for substantial investment in palliative care research to address these knowledge gaps, but despite billions of dollars spent on research in cardiovascular disease, chronic obstructive pulmonary disease (COPD), Alzheimer’s and related dementias, and cancer, there has been almost no investment in research that might significantly alleviate the physical symptoms; psychological distress; and personal care, family, and social needs of older persons living with advanced illness.One of the major contributing factors to low levels of research support for care of people with serious and complex illnesses is that there is no federal agency specifically charged with that mission. With few exceptions, the National Institutes of Health (NIH) are disease-specific and thus palliative care with its applicability to all serious illnesses does not fit well within one particular institute. The National Cancer Institute (NCI), the National Institute on Aging (NIA), the Agency for Healthcare Research and Quality (AHRQ), and the National Institute of Nursing Research (NINR) have supported some research in palliative care but it is not a priority in any of these agencies’ annual budgets.Pilot data results are typically needed before a federal agency (e.g., NIH, VA) or the American Cancer Society will consider funding a research project. In an effort to support clinician investigators conducting patient-oriented research in palliative care who wish to maximize their chances of larger extramural funding, the American Cancer Society, in parallel with the National Palliative Care Research Center (NPCRC), is soliciting applications for pilot/exploratory research grants in palliative care of cancer patients and their families.FOCUS of RFA: This RFA provides funding for investigators performing pilot and exploratory research studies whose purpose is to test interventions, develop research methodologies, and explore novel areas of research in palliative care of cancer patients and their families. A condition of funding is a clearly defined plan as to how the investigator will use the results of the project to develop larger, extramurally funded research projects.This RFA is limited to applications that focus on palliative care research projects for seriously ill cancer patients and their families in three specific areas:1. Exploring the relationship of pain and other distressing symptoms on quality and quantity of life, independence, function, and disability and developing interventions directed at their treatment in patients with advanced and chronic illinesses;2. Studying methods of improving communication between adults living with serious illness, their families and their health care providers;3. Evaluating models and systems of care for patients living with advanced illness and their families.As a condition of accepting the award, each recipient of this grant, will agree to:1. Attend the required meetings of the NPCRC in Fall during the award period.2. Present results of the funded research at this required NPCRC meeting;3. Prepare annual progress reports for each year of funding and a final report at the conclusion of the award period.4. List the American Cancer Society as funding this study on all publications and presentations.ELIGIBILITY REQUIREMENTS:1. Applications may be submitted by not-for-profit institutions located within the United States, its territories and the Commonwealth of Puerto Rico.2. Applicants must be United States citizens, non-citizen nationals or permanent residents of the United States.3. Applicants must hold a doctorate degree (MD, PhD, or equivalent) and have a full-time faculty position or equivalent at a college, university, medical school, or other fiscally responsible not-for-profit organization within the United States. Independent investigators at all stages of their career are eligible to apply. Thus, the usual ACS restriction to investigators within the first six years of their initial independent research appointment does not apply to this RFA.MECHANISM OF SUPPORT: Mechanism: This RFA will use the American Cancer Society Pilot and Exploratory Projects (PEP) award mechanism. Complete instructions on this grant mechanism can be found here Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families Policies and Instructions. Length of Study: Awards may not exceed a period of one to two years duration. Budget: Awards may not exceed $60,000 per year (direct costs) plus 20% indirect costs. Salary support for the Principal Investigator may not exceed 20% of the direct costs.
Awards: It is anticipated that a total of $500,000 per year for five years (starting in 2006) will be available for applications selected through the Society's peer review system.DEADLINE: Applicants must submit their full application electronically and in paper format per guidelines on cancer.org no later than 5pm (Eastern) on October 15th.PEER REVIEW OF APPLICATIONSReview of applications at the American Cancer Society is a two-tiered process:
Step 1: Applications will first be reviewed by the Palliative Care Research committees. Applications considered for funding will be recommended to the Council for Extramural Grants Research.
Step 2: Applications considered for funding will be reviewed by the Council for Extramural Grants. After considering the relative merit of the applications, the available funds and the Society’s objectives, the Council will determine who will be funded.ADDITIONAL QUESTIONSDue to the high number of expected applications, please contact our office only if the answer is not clearly stated in the guidelines here or online at www.cancer.org. Please contact Dr. Ronit Elk by email only: ronit.elk@cancer.orgKEY DATES:Proposal Deadline: October 15Applications Reviewed in Committee: JanuaryPreliminary Notification of Outcome: MarchApplications Reviewed in Council: MarchNotifications of Awards: AprilAward Start Date: July 1Note: grant application materials become available July 1.
123next
